搜尋結果
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 11 小時前Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the ...
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters· 10 小時前, opens new tab on Friday said its popular weight-loss drug Zepbound helped resolve moderate to ...
Weight loss drug contender Zealand Pharma jumps 18% on trial results
CNBC· 21 小時前... popped on Friday, notching a record high after an early-stage study of its weight ... ...
Weight-Loss Drugs Dangers Explained: Zepbound, Mounjaro Maker Warn Of Coming Counterfeit ...
Forbes· 2 日前Several medical spas and wellness centers are facing potential lawsuits from drugmaker Eli ...
Student loan forgiveness deadline is June 30. Here's what borrowers need to know
CNBC· 2 日前Student loan borrowers have until the end of June to meet a deadline that could lead to quicker ...
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
CNBC· 4 日前More U.S. employers are covering a buzzy class of medications called GLP-1s for weight loss, a ...
Focus: Food companies with Ozempic-friendly snacks and meals wade carefully into weight-loss wa ...
Reuters· 2 日前, opens new tab new food brand for people taking weight-loss drugs like Wegovy will note that ...
Weight-loss options for US youth are hard to come by
Reuters· 5 日前For many U.S. parents seeking help for a child with obesity, the most widely-endorsed treatment ...
Mounjaro Drug Tirzepatide Could Treat Sleep Apnea, Study Finds
Forbes· 1 日前Eli Lilly’s weight loss injection tirzepatide — the ingredient inside its wildly popular drugs Mounjaro ...
Ron Insana: Never mind the narrow leadership. This is a powerful bull market
CNBC· 11 小時前There has been a fair amount of nervous chatter lately about the state of the stock market. ...